Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
Melhem-Bertrandt A, Bojadzieva J, Ready KJ, Obeid E, Liu DD, Gutierrez-Barrera AM, Litton JK, Olopade OI, Hortobagyi GN, Strong LC, Arun BK.
Melhem-Bertrandt A, et al.
Cancer. 2012 Feb 15;118(4):908-13. doi: 10.1002/cncr.26377. Epub 2011 Jul 14.
Cancer. 2012.
PMID: 21761402
Free PMC article.